EUVIMEDEUVIMED entdecken
Crossref

Astragalin alleviates ulcerative colitis via FPR1 inhibition and restores Microbiota-Metabolite Homeostasis: A mechanism revealed by deep learning

Fang Zhang, Cong Wang, Yan Zuo, Haonan Xu, Yan Che, Yu Cui, Qisheng Yao, Yongtao Sun, Ke Che, Hao Chen

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.118022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Fang Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of life and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China; School of Food Engineering, Anhui Science and T…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Kaempferols, Homeostasis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Anhui Provincial Key Research and Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pursuit of multi-targeted therapies that simultaneously address mucosal immune dysregulation, barrier dysfunction and gut microbiota imbalance in ulcerative colitis (UC) remains a major challenge. Astragalin, a natural flavonoid, represents a promising therapeutic candidate, yet its mechanisms of action have remained poorly defined. Here, we used an integrated deep-learning platform that combines multiple neural architectures to predict a high-confidence target of Astragalin, and then validated these predictions in a DSS-induced murine colitis model using pharmacological assays, 16S rRNA sequencing, untargeted metabolomics and complementary cellular studies. Our framework identified formyl peptide receptor 1 (FPR1) as a high-confidence target, and we show that Astragalin directly binds to FPR1, promotes its degradation through a proteasome-dependent pathway and consequently inhibits NF-κB activation. Consistent with this mechanism, Astragalin ameliorated colitis symptoms, suppressed pro-inflammatory cytokines and enhanced intestinal barrier integrity. Beyond host signalling, Astragalin restored gut microbial ecology, notably enriching Akkermansia muciniphila, and reversed colitis-associated metabolic disturbances, with prominent effects on glutathione and L-ascorbate metabolism. Correlation analyses further revealed a strong positive association between A. muciniphila abundance and key protective metabolites. Together, these findings uncover Astragalin as a natural FPR1 inhibitor that alleviates colitis through a self-reinforcing circuit involving targeted protein degradation, suppression of inflammation, restoration of a beneficial microbiota and reinforcement of the mucosal barrier, positioning Astragalin as a multi-faceted therapeutic strategy for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeKaempferolsHomeostasisGastrointestinal MicrobiomeReceptors, Formyl PeptideAnimalsMiceMice, Inbred C57BLMaleHumans

Stichwörter der Autor:innen

AkkermansiaAstragalinDeeppurposeFormyl Peptide Receptor 1Microbiota-Metabolite AxisUlcerative Colitis

Substanzen

KaempferolsastragalinReceptors, Formyl Peptide

Autor:innen und Institutionen

  • College of life and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China; School of Food Engineering, Anhui Science and Technology University, Fengyang 233100, China.
  • Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing 210094, China.
  • The First Affiliated Hospital of Anhui Medical University, Hefei 230000, China.
  • College of life and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China; College of Animal Science, Anhui Science and Technology University, Fengyang 233100, China.
  • School of Food Engineering, Anhui Science and Technology University, Fengyang 233100, China.
  • College of Animal Science, Anhui Science and Technology University, Fengyang 233100, China.

Förderung

  • Anhui Provincial Key Research and Development Plan

Zitieren

APA

Zhang, F., Wang, C., Zuo, Y., Xu, H., Che, Y., Cui, Y., Yao, Q., Sun, Y., Che, K., & Chen, H. (2026). Astragalin alleviates ulcerative colitis via FPR1 inhibition and restores Microbiota-Metabolite Homeostasis: A mechanism revealed by deep learning. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118022

Vancouver

Zhang F, Wang C, Zuo Y, Xu H, Che Y, Cui Y, et al. Astragalin alleviates ulcerative colitis via FPR1 inhibition and restores Microbiota-Metabolite Homeostasis: A mechanism revealed by deep learning. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118022

BibTeX
@article{Zhang2026,
  author = {Zhang, Fang and Wang, Cong and Zuo, Yan and Xu, Haonan and Che, Yan and Cui, Yu and Yao, Qisheng and Sun, Yongtao and Che, Ke and Chen, Hao},
  title = {Astragalin alleviates ulcerative colitis via FPR1 inhibition and restores Microbiota-Metabolite Homeostasis: A mechanism revealed by deep learning},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.118022}
}
Kostenlos starten →